Nano Dimension Ltd.
NNDMNasdaqTechnology · Printed Circuit Boards · L3 · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | |
|---|---|---|---|
| Revenue | $102.4M | $57.8M | $56.3M |
| Operating income | −$140.3M | −$89.6M | −$129.3M |
| Net income | −$293.3M | −$98.8M | −$56.0M |
| Total assets | $638.2M | $902.5M | — |
| Total liabilities | $86.2M | $41.8M | — |
| Equity | $552.0M | $860.0M | $1.02B |
| EPS (diluted) | $-1.36 | $-0.45 | $-0.23 |
| Shares out. | 215,742 | 218,311 | 248,019 |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −137.0%
- Net margin
- −286.3%
- Return on equity
- −53.1%
- Return on assets
- −46.0%
- Return on capital (ROCE)
- −24.0%
- Liabilities / assets
- 13.5%
- Debt / equity
- 0.16×
- Book value / share
- $2558.56
- Revenue growth (YoY)
- 77.3%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Accruals / assets
- −34.9%clean
- Beneish M-Score
- -3.27normal
- Piotroski F-Score
- 4/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 3 warning● 3 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Mar 16, 2026
- NT 20-Fmissed a reporting deadline ↗Apr 30, 2025
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Murchinson Ltd.Activist (13D)May 21, 2026
- Oramed Pharmaceuticals Inc.Activist (13D)Feb 19, 2026
- Anson Funds Management LpActivist (13D)Jul 14, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Borenstein PhillipDirector | Jan 1, 2026 | Grant | 60,000 | $0.00 |
| Pons Robert MDirector | Jan 1, 2026 | Grant | 260,000 | $0.00 |
| Stehlin DavidOfficer — Chief Executive Officer | Jan 1, 2026 | Grant | 200,000 | $0.00 |
| Brenton JohnOfficer — Chief Financial Officer | Mar 24, 2026 | Tax withholding | 20,043 | $1.65 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 12.4M | 4.1 | +8.0% |
| Apr 30, 2026 | 11.5M | 7.5 | -3.7% |
| Apr 15, 2026 | 11.9M | 6.0 | +2.4% |
| Mar 31, 2026 | 11.7M | 4.3 | +6.0% |
| Mar 13, 2026 | 11.0M | 8.4 | -0.0% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Other material eventMay 27, 2026
- Regulation FD disclosureMay 26, 2026
- Results of operationsMay 7, 2026
- Other material eventApr 30, 2026
- Other material eventApr 6, 2026
- Results of operationsMar 31, 2026
- Entered a material agreement · Delisting / listing-standard notice · Other material eventFeb 3, 2026
- Results of operationsJan 21, 2026
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 4OWNERSHIP DOCUMENTMay 29, 2026
- 4OWNERSHIP DOCUMENTMay 29, 2026
- 4OWNERSHIP DOCUMENTMay 29, 2026
- 4OWNERSHIP DOCUMENTMay 29, 2026
- 3OWNERSHIP DOCUMENTMay 29, 2026
- 3OWNERSHIP DOCUMENTMay 29, 2026
- 3OWNERSHIP DOCUMENTMay 29, 2026
- 3OWNERSHIP DOCUMENTMay 29, 2026
- 8-KMay 27, 2026
- DEFA14AMay 26, 2026
- 8-KFORM 8-KMay 26, 2026
- SCHEDULE 13D/AMay 21, 2026
- 144May 15, 2026
- 144May 12, 2026
- 10-QMay 7, 2026